Thymoquinone-loaded nanostructured lipid carriers: Preparation, gastroprotection, in vitro toxicity, and pharmacokinetic properties after extravascular administration

International Journal of Nanomedicine

Volumn 8, Issue , 2013, Pages 2163-2172

  Abdelwahab, Siddig Ibrahim ^a   Sheikh, Bassem Yousef ^b   Taha, Manal Mohamed Elhassan ^a   How, Chee Wun ^c   Abdullah, Rasedee ^c   Yagoub, Umar ^a   El Sunousi, Rashad ^a   Eid, Eltayeb E M ^a  

^a JAZAN UNIVERSITY   (Saudi Arabia)

^b TAIBAH UNIVERSITY   (Saudi Arabia)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Black seed oil; Gastric ulcer; Lipid based nanoparticles

Indexed keywords

ALCOHOL; CISPLATIN; DRUG CARRIER; HEAT SHOCK PROTEIN 70; HYDROGEN; NANOSTRUCTURED LIPID CARRIER; OLIVE OIL; OMEPRAZOLE; PALM OIL; PHOSPHATIDYLCHOLINE; POLYSORBATE 80; SORBITOL; THIOMERSAL; THYMOQUINONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG CYTOTOXICITY; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG SAFETY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL; LIVER TOXICITY; MALE; MAXIMUM PLASMA CONCENTRATION; MORPHOLOGY; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; RABBIT; RAT; STOMACH MUCUS; STOMACH PH; STOMACH PROTECTION; STOMACH ULCER; TIME TO MAXIMUM PLASMA CONCENTRATION; ZETA POTENTIAL;

BLACK SEED OIL; GASTRIC ULCER; LIPID BASED NANOPARTICLES;

ANIMALS; BENZOQUINONES; CELL LINE; CELL SURVIVAL; DRUG CARRIERS; HISTOCYTOCHEMISTRY; HUMANS; MALE; NANOPARTICLES; NIGELLA SATIVA; PARTICLE SIZE; PROTECTIVE AGENTS; RABBITS; RATS; RATS, SPRAGUE-DAWLEY; STOMACH; STOMACH ULCER;

NIGELLA SATIVA; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 84879142419     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S44108     Document Type: Article

References (45)

1. Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res. 2000;14(5):323-328.
2. Ali BH, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res. 2003;17(4):299-305.
3. Woo CC, Kumar AP, Sethi G, Tan KH. Thymoquinone: potential cure for inflammatory disorders and cancer. Biochem Pharmacol. 2012;83(4):443-451.
4. Ammar el-SM, Gameil NM, Shawky NM, Nader MA. Comparative evaluation of anti-inflammatory properties of thymoquinone and curcumin using an asthmatic murine model. Int Immunopharmacol. 2011;11(12):2232-2236.
5. Mariod AA, Ibrahim RM, Ismail M, Ismail N. Antioxidant activity and phenolic content of phenolic rich fractions obtained from black cumin (Nigella sativa) seedcake. Food Chem. 2009;116(1):306-312.
6. Bourgou S, Pichette A, Marzouk B, Legault J. Bioactivities of black cumin essential oil and its main terpenes from Tunisia. S Afr J Bot. 2010;76(2):210-216.
7. El-Abhar HS, Abdallah DM, Saleh S. Gastroprotective activity of Nigella sativa oil and its constituent, thymoquinone, against gastric mucosal injury induced by ischaemia/reperfusion in rats. J Ethnopharmacol. 2003;84(2-3):251-258.
8. Ravindran J, Nair HB, Sung B, Prasad S, Tekmal RR, Aggarwal BB. Thymoquinone poly (lactide-co-glycolide) nanoparticles exhibit enhanced anti-proliferative, anti-inflammatory, and chemosensitization potential. Biocheml Pharmacol. 2010;79(11):1640-1647.
9. Zaoui A, Cherrah Y, Lacaille-Dubois MA, Settaf A, Amarouch H, Hassar M. [Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat]. Therapie. 2000;55(3):379-382. French.
10. Salem ML. Immunomodulatory and therapeutic properties of the Nigella sativa L seed. Int Immunopharmacol. 2005;5(13-14):1749-1770.
11. Kanter M, Demir H, Karakaya C, Ozbek H. Gastroprotective activity of Nigella sativa L oil and its constituent, thymoquinone against acute alcohol-induced gastric mucosal injury in rats. World J Gastroenterol. 2005;11(42):6662-6666.
12. Hyder MAH. [Nanotechnology and Environment: Potential Applications and Environmental Implications of Nanotechnology] [master's thesis]. Hamburg: Hamburg University of Technology; 2003. German.
13. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002;54 Suppl 1: S131-S155.
14. Marcato PD, Durain N. New aspects of nanopharmaceutical delivery systems. J Nanosci Nanotechnol. 2008;8(5):2216-2229.
15. Shidhaye SS, Vaidya R, Sutar S, Patwardhan A, Kadam VJ. Solid lipid nanoparticles and nanostructured lipid carriers-innovative generations of solid lipid carriers. Curr Drug Deliv. 2008;5(4):324-331.
16. Patidar A, Thakur DS, Kumar P, Verma J. A review on novel lipid based nanocarriers. Int J Pharm Pharm Sci. 2010;2(4):30-35.
17. Raffin RP, Colomé LM, Pohlmann AR, Guterres SS. Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. Eur J Pharm Biopharm. 2006;63(2):198-204.
18. Arias J, Clares B, Morales M, Gallardo V, Ruiz MA. Lipid-based drug delivery systems for cancer treatment. Curr Drug Targets. 2011; 12(8):1151-1165.
19. Müller RH, Mäder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161-177.
20. Thiruganesh R, Uma Devi SK. Solid lipid nanoparticle and nanoparticle lipid carrier for controlled drug delivery-a review of state of art and recent advances. Intl J of Nanoparticles. 2010;3(1):32-52.
21. Hauss DJ. Oral lipid-based formulations. Adv Drug Deliv Rev. 2007;59(7):667-676.
22. Kumar H, Dharamveer KMK, Saraf AS. Preparation, characterization and in vivo anti-ulcer evaluation of ranitidine-loaded floating microparticles. Proceedings of the National Conference on Innovations in Drug Delivery and Research; March 3-5, 2009; Patiala, India.
23. Cardoso T, Galhano CIC, Ferreira Marques MF, Moreira da Silva A. Thymoquinone beta-Ccyclodextrin nanoparticles system: a preliminary study. Journal of Spectroscopy. 2012;27(5-6):329-336.
24. Alam S, Khan ZI, Mustafa G, etal. Development and evaluation of thymoquinone-encapsulated chitosan nanoparticles for nose-to-brain targeting: a pharmacoscintigraphic study. Int J Nanomedicine. 2012;7:5705-5718.
25. How CW, Abdullah R, Abbasalipourkabir R. Physicochemical properties of nanostructured lipid carriers as colloidal carrier system stabilized with polysorbate 20 and polysorbate 80. Afr J Biotechnol. 2011;10(9):1684-1689.
26. Potrich FB, Allemand A, da Silva LM, etal. Antiulcerogenic activity of hydroalcoholic extract of Achillea millefolium L: involvement of the antioxidant system. J Ethnopharmacol. 2010;130(1):85-92.
27. Tan PV, Nyasse B, Dimo T, Mezui C. Gastric cytoprotective anti-ulcer effects of the leaf methanol extract of Ocimum suave (Lamiaceae) in rats. J Ethnopharmacol. 2002;82(2):69-74.
28. Njar VCO, Adesanwo JK, Raji Y. Methyl angolensate: The antiulcer agent from the stem bark of Entandrophragma angolense. Planta Med. 1995;61(1):91-92.
29. Behmer OA. Manual de Técnicas para Histologia Normal e Patológica [Technical Manual for Normal and Pathological Histology]. São Paulo: Edart; 1976. Portuguese.
30. Vacca LL. Laboratory Manual of Histochemistry. New York, NY: Raven Press; 1985.
31. Eid EEM, Abdul AB, Al-Zubairi AS, Sukari MA, Abdullah R. Validated high performance liquid chromatographic (HPLC) method for analysis of zerumbone in plasma. Afr J Biotechnol. 2010;9(8):1260-1265.
32. Seetapan N, Bejrapha P, Srinuanchai W, Ruktanonchai UR. Rheological and morphological characterizations on physical stability of gamma-oryzanol-loaded solid lipid nanoparticles (SLNs). Micron. 2010;41(1): 51-58.
33. Huang Z, Hua SC, Yang YL, Fang JY. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion. Acta Pharmacol Sin. 2008;29(9):1094-1102.
34. How CW, Abdullah R, Abbasalipourkabir R. Characterization and cytotoxicity of nanostructured lipid carriers formulated with olive oil, hydrogenated palm oil and polysorbate 80. IEEE Trans Nanobioscience. Epub December 20, 2012.
35. Wong HL, Bendayan R, Rauth AM, Li Y, Wu XY. Chemotherapy with anticancer drugs encapsulated in solid lipid nanoparticles. Adv Drug Deliv Rev. 2007;59(6):491-504.
36. Puri A, Loomis K, Smith B, etal. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-580.
37. Kelly S, Hunter JO. Epidermal growth factor stimulates synthesis and secretion of mucus glycoproteins in human gastric mucosa. Clin Sci (Lond). 1990;79(5):425-427.
38. Morris GP, Wallace JL. The roles of ethanol and of acid in the production of gastric mucosal erosions in rats. Virchows Arch B Cell Pathol Incl Mol Pathol. 1981;38(1):23-38.
39. Andreo MA, Ballesteros KVR, Hiruma-Lima CA, Machado da Rocha LR, Souza Brito AR, Vilegas W. Effect of Mouriri pusa extracts on experimentally induced gastric lesions in rodents: role of endogenous sulfhydryls compounds and nitric oxide in gastroprotection. J Ethnopharmacol. 2006;107(3):431-441.
40. Ramteke S, Jain NK. Clarithromycin-and omeprazole-containing gliadin nanoparticles for the treatment of Helicobacter pylori. J Drug Target. 2008;16(1):65-72.
41. Lupidi G, Camaioni E, Khalifé H, Avenali L, Damiani E, Tanfani F. Characterization of thymoquinone binding to human α1-acid glycoprotein. J Pharmaceut Sci. 2012;101:2564-2573.
42. Tajau R, Dahlan KZM, Mahmood MH, etal. Acrylated vegetable oil nanoparticle as a carrier and controlled release of the anticancer drug-thymoquinone. Proceedings of the 2012 International Conference on Enabling Science and Nanotechnology; January 5-7, 2012. IEEE Conference Publications; 2012. Available from: http://ieeexplore.ieee.org/xpl/login.jsp?tp=&arnumber=6149656&url=http%3A%2F%2Fieeexplore.ieee.org%2Fstamp%2Fstamp.jsp%3Ftp%3D%26arnumber%3D6149656. Accessed April 14, 2013.
43. Collnot EM, Ali H, Lehr CM. Nano-and microparticulate drug carriers for targeting of the inflamed intestinal mucosa. J Control Release. 2012; 161(2):235-246.
44. Singh A, Ahmad I, Akhter S, etal. Nanocarrier based formulation of thymoquinone improves oral delivery: stability assessment, in-vitro and in-vivo studies. Colloids Surf B Biointerfaces. 2013;102:822-832.
45. Pathan SA, Jain GK, Zaidi S, etal. Stability-indicating ultra-performance liquid chromatography method for the estimation of thymoquinone and its application in biopharmaceutical studies. Biomed Chromatogr. 2011;25(5):613-620.